title: An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder.
authors.forename: Javier
authors.initials: J
authors.lastname: Ballesteros
authors.forename: Luis F
authors.initials: LF
authors.lastname: Callado
authors.forename: Miguel
authors.initials: M
authors.lastname: Gutiérrez
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D000068736:Duloxetine Hydrochloride; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D018687:Antidepressive Agents, Second-Generation; D013876:Thiophenes; D017374:Paroxetine; D000068736:Duloxetine Hydrochloride